Lv2
130 积分 2022-11-16 加入
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
17小时前
待确认
Pharmacokinetic and Pharmacodynamic Modeling of siRNA Therapeutics – a Minireview
1个月前
已完结
Drug-Drug Interaction Prediction on a Biomedical Literature Knowledge Graph
1个月前
已完结
Artificial Intelligence in Clinical Pharmacology: A Case Study and Scoping Review of Large Language Models and Bioweapon Potential
1个月前
已完结
A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trial
2个月前
已完结
Estimation of time to progression and post progression survival using joint modeling of summary level OS and PFS data with an ordinary differential equation model
2个月前
已完结
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
2个月前
已完结
A randomized phase I study of the safety and pharmacokinetics of BI 1291583 in healthy Japanese male subjects
3个月前
已完结
CMC Regulatory Considerations for Antibody-Drug Conjugates
3个月前
已完结
Safety, tolerability, pharmacokinetics(PK) and pharmacodynamics(PD) of HSK31858，a novel DPP-1 inhibitor in healthy volunteers：a phase I clinical trial
4个月前
已关闭
皖公网安备34019202002308
